Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations

Regulatory changes have been enacted in the United States (US) and European Union (EU) to encourage the development of new treatments for pediatric cancer. Here, we review some of the factors that have hampered the development of pediatric cancer treatments and provide a comparison of the US and EU...

Descripción completa

Detalles Bibliográficos
Autores principales: Barry, Elly, Walsh, Jaimie A., Weinrich, Scott L., Beaupre, Darrin, Blasi, Eileen, Arenson, Daniel R., Jacobs, Ira A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275539/
https://www.ncbi.nlm.nih.gov/pubmed/34173206
http://dx.doi.org/10.1007/s40272-021-00455-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275539/
https://www.ncbi.nlm.nih.gov/pubmed/34173206
http://dx.doi.org/10.1007/s40272-021-00455-1

Ejemplares similares